RPR To Pursue Synercid Pneumonia Indication With Early-2000 Submission

Rhone-Poulenc Rorer will submit results of a second hospital-acquired pneumonia study to FDA in early-2000 to broaden the indication for its injectable streptogramin antibiotic Synercid.